Microsoft Research unveils Quine, a multimodal ‘world model of biology’ validated in pancreatic-cancer screens with the Broad Institute
Awaiting review
The takeaway
On Sept 29, 2026 Microsoft Research introduced Quine, an early-stage AI research system that learns shared representations across genomics, proteins, chemistry, cell state and bioimaging and is wired into a tool/literature harness.
Status
- Claim
Awaiting review
- Our reporting
- Medium confidence
- Verification
- Unverified claim
- Importance
- 2 of 5
- Last verified
- 5 October 2026
Your AI and this story
- GPT-6.2 Astra121 days after its cutoff
- Claude Opus 5.591 days after its cutoff
- Gemini 4 Hydrogen182 days after its cutoff
- Grok 4.7121 days after its cutoff
None of these four assistants can know about it. The closest, Claude Opus 5.5, stops 91 days before it.
Key facts
- Announced Sept 29, 2026 by Nicolo Fusi (VP, Distinguished Scientist) and Jonathan M. Carlson (VP), Microsoft Research
- Multimodal model across genomics, proteins, chemistry, cellular state and bioimaging, plus a harness connecting tools, literature and researchers in a closed loop with wet-lab experiments
- PDAC case study with the Broad Institute: thousands of compounds predicted and prioritized for cell-state transitions in about one weekend; top candidates gave the largest intended transcriptional shifts; predictions pointed to a third phenotype beyond the classical/basal axis and to repurposing candidates (company claims, no paper linked)
- Access: Quine Fellows program (applications open) and selected collaborations; planned to reach customers through Microsoft Discovery; research use only
What happened
Microsoft Research presented Quine as a step toward a “world model of biology” that lets scientists search far more interventions computationally than intuition allows, then test the best in the lab. The only result shown is a PDAC compound-prioritization study with the Broad Institute; no paper, benchmark or weights were released.
Why it matters
It joins a crowded field of lab-in-the-loop biology agents (FutureHouse/Edison Robin, Lila, OpenAI GPT-Rosalind) and is Microsoft’s first named biology foundation-model effort tied to its Discovery platform.
What is disputed or not yet verified
| Verification | lab-validated (company-reported; no peer-reviewed paper yet) |
|---|
Sources
1 source from 1 site. Numbers match the chips in the text.
1 source: 1 primary
Primary
Changes
- Filed